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Mitochondrial STAT3Neurturin (NRTN), a member of the GDNF family of ligands (GFL), is currently investigated in a series of clinical
trials for Parkinson's disease. NRTN signals through its cognate receptor GFRα2 and co-receptor RET to induce
neurite outgrowth, but the underlying mechanism remains to be better understood. STAT3 was previously
shown to be activated by oncogenic RET, independent of ligand and GFRα. In this study, we demonstrated that
NRTN induced serine727 but not tyrosine705 phosphorylation of STAT3 in primary cortical neuron and neuronal
cell lines. Remarkably, STAT3 phosphorylation was found to be mediated speciﬁcally by GFRα2c and RET9
isoforms. Furthermore, serine but not tyrosine dominant negative mutant of STAT3 impaired NRTN induced
neurite outgrowth, indicative of the role of STAT3 as a downstream mediator of NRTN function. Similar to NGF,
the NRTN induced P-Ser-STAT3 was localized to the mitochondria but not to the nucleus. Mitochondrial STAT3
was further found to be intimately involved in NRTN induced neurite outgrowth. Collectively, these ﬁndings
demonstrated the hitherto unrecognized and novel role of speciﬁc GFRα2 and RET isoforms in mediating
NRTN activation of STAT3 and the transcription independent mechanism whereby the mitochondria localized
P-Ser-STAT3 mediated NRTN induced neurite outgrowth.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Neurturin (NRTN) is a member of the glial cell line-derived
neurotrophic factor (GDNF) family of ligands (GFLs) which have
been shown to support the growth, maintenance and differentiation of
both central and peripheral nervous systems [1]. Multiple clinical trial
evaluating NRTN based gene therapy for Parkinson's disease are current-
ly underway (Phase II, Ceregene, NCT00985517 etc.). NRTN transduces
signals through a multi-component receptor complex consisting of GPI
anchored GDNF family receptor alpha 2 (GFRα2) and trans-membrane
co-receptors RET (RE arranged during Transformation) or neural cell ad-
hesion molecule (NCAM) [2–4]. NRTN-GFRα2 signalling is crucial for
neuronal development. Mice lacking NRTN and GFRα2 signalling suffer
from deﬁcits in target innervations in both sympathetic [5] and para-
sympathetic neurons [6]. Furthermore, in GFRα2 knockout mouse,
NRTN stimulation failed to initiate axonal outgrowth of DRG neurons,
supporting the physiological role of GFRα2 in neuronal differentiation
[7]. Multiple alternatively spliced isoforms of GFRα2 have beenfactor; GFL:GDNF family ligand;
RE arranged during Transforma-
n 3; NCAM: neural cell adhesion
re, Department of Biochemistry,
6516 3687.
o).
ights reserved.reported [8] and were found to bewidely expressed in the nervous sys-
tem. Interestingly, NRTN stimulation of GFRα2a and GFRα2c induced
neurite outgrowth whereas ligand stimulation of GFRα2b inhibited
neurite outgrowth, highlighting the distinct biochemical and neuritogenic
functions of these receptor isoforms [9,10]. Similarly, RET [11] and NCAM
isoforms [12] were also found to exert distinct functions in neuronal sys-
tems. Understanding the combinatorial interactions between GFRα2, RET
and NCAM isoformswill provide novel insights into the diverse functions
of NRTN and the underlying signalling network.
Signal Transducer and Activator of Transcription 3 (STAT3) is a clas-
sic transcription regulator thatmediates amyriad of biological functions
in multiple cellular systems [13]. In neuronal systems, STAT3 plays crit-
ical roles during neural development and mediates the protective and
regenerative effects of multiple neurotrophic factors upon nerve inju-
ries [13]. The canonical pathway of STAT3 activation involves ligand in-
duced phosphorylation of tyrosine705 residue (P-Tyr-STAT3), resulting
in STAT3nuclear translocation and activation of target gene transcription
[14]. STAT3 can also be phosphorylated at serine727 (P-Ser-STAT3), but
its functional signiﬁcance remains controversial. Serine phosphorylation
can enhance or suppress the transcriptional activity of tyrosine phos-
phorylated STAT3 in a cell context dependent manner [15,16]. More re-
cently, STAT3 has also been shown to localize to the mitochondria and
exert functions independent of its transcriptional activities [17,18].
GFL independent activation of STAT3 by oncogenic RET has been ob-
served. Depending on the type of mutations, different oncogenic RET
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phosphorylation or dual tyrosine and serine phosphorylation of STAT3
[19,20]. In addition, the signaling pathways mediating oncogenic RET
induced STAT3 phosphorylation vary across cell types. In ARO cells,
the intrinsic kinase activity of oncogenic RET alonewas found to be suf-
ﬁcient to induce STAT3 phosphorylation [21]. In other cell models, mu-
tant RET activated a Src/JAK/STAT3 pathway which was shown to be
independent of ligand [22]. From these studies, a pertinent and obvious
question is whether STAT3 can be activated by the interactions of the
wild type RET, as a co-receptor, with GFLs and GFRα.
In this study, we tested the hypothesis that STAT3 can be activated by
NRTN-GFRα2 signaling and may in turn mediate the neuritogenic func-
tions of NRTN. STAT3 was found to be serine mono-phosphorylated
upon NRTN stimulation. The involvement of speciﬁc GFRα2 and RET
isoforms in NRTN induced P-Ser-STAT3 was further investigated in mul-
tiple cell models. Moreover, serine but not tyrosine dominant negative
mutant of STAT3 was found to impair NRTN induced neurite outgrowth.
Similar to our earlier study on NGF, NRTN induced P-Ser-STAT3 was
found to be localized to the mitochondria but not the nucleus. The mito-
chondrial P-Ser-STAT3 was further shown to be intimately involved in
NRTN induced neurite outgrowth. To the best of our knowledge, this is
the ﬁrst report demonstrating the activation of STAT3 by a GFL through
the interaction of the wild type RET and a GFRα. Our ﬁndings further il-
lustrated the distinct functions of GFRα2 and RET isoforms and showed
the transcription-independentmechanismwherebymitochondria local-
ized STAT3 mediates NRTN induced neurite outgrowth.
2. Materials and methods
2.1. Cell culture
The murine neuroblastoma cell line Neuro2A cells (American Type
Culture Collection; catalog # CCL-131) were grown in DMEM (Sigma,
St. Louis, MO) supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Sigma), 100 units/ml penicillin (Pan Biotech, Germany)
and 100 μg/ml streptomycin (Pan Biotech), at 37 °C in a humidiﬁed at-
mosphere with 5% CO2. The rat pheochromocytoma cell line PC12 cells
(American Type Culture Collection; catalog # CRL-1721) were grown in
DMEM (Sigma, St. Louis, MO) supplemented 10% heat-inactivated FBS,
5% Horse Serum (HS, Hyclone, Logan, UT), 100 units/ml penicillin and
100 μg/ml streptomycin. For studies on ligand induced signaling activa-
tion and neurite outgrowth, Neuro2A and PC12 cells were serum starved
in DMEM with 1/20 of original serum content (0.5% FBS for Neuro2A
and 0.25% HS, 0.5% FBS for PC12) for 12–16 h before stimulated with
50 ng/ml ofNRTN (PeproTech, London, UK) or IL6 (PeproTech). For inhib-
itor studies, the cells were pre-treated with U0126 (Promega), SP600125
(Tocris, Bristol, UK), SB203580 (Tocris), PP2 (Tocris), SU6656 (Sigma), or
Gö6983 (Sigma) for 1 h before stimulated with NRTN in the presence of
these inhibitors.
2.2. Primary culture
Rat primary cortical neurons were isolated from embryonic day 18
(E18) rat embryos, as described previously [23]. Brieﬂy, the cortices
were dissected and dissociated in Hank's balanced salt solution (Sigma),
and plated on poly-D-lysine (Sigma) coated culture plates in Minimal es-
sential medium (MEM, Sigma) supplemented with glucose (0.6% wt/vol,
Sigma) and 10% FBS. After 24 h, MEMwas replaced by Neurobasal medi-
um (Invitrogen, Carlsbad, CA) containing B27 supplement (Invitrogen),
2 mM glutamine (Invitrogen), 100 units/ml penicillin and 100 μg/ml
streptomycin and continued to culture for 48 h at 37 °C in a humidiﬁed
atmospherewith 5% CO2. OnDIV 3 (3 days in vitro), primary cortical neu-
rons were washed once with Neurobasal medium without B27 and kept
in the same medium for 3 h before stimulated with 100 ng/ml NRTN.
All procedures were performed according to the guidelines issued by
the National University of Singapore Institutional Animal Care & UseCommittee (IACUC). This study was approved under a broader project
titled “Mechanism elucidation and application of global Transcriptional
Machinery Engineering (gTME) to themodulation of the isoprenoid pathway
for biosynthesis of pharmaceutical” and given the animal work permits
(072/09).2.3. Construction of retroviral vectors containing wild type and mutant
STAT3 and transient transfection
The vector construction has been described previously [23]. The
wild type and three mutant forms of STAT3a (Ser727Ala, Ser727Glu,
Tyr705Phe) were kindly provided by Dr. Cao Xinming (Institute of
Molecular and Cellular Biology, Singapore). For transient expression
studies, wild type and mutant STAT3a constructs were sub-cloned
into a modiﬁed murine retroviral pQCXI vector (Clontech, Mountain
View, CA) that harbors an eGFP-coding sequence under the control
of an internal ribosomal entry site (pQCXI-eGFP). For mitochondria
targeted STAT3 constructs, the mitochondrial targeting sequence (MTS)
from cytochrome c oxidase subunit VIII was ﬁrst cloned and fused to
the 5′ of wild type and mutant STAT3a by assembly PCR and subcloned
into the retroviral pQCXI-P vector containing puromycin resistance
gene as selection marker.2.4. Transient transfection of Neuro2A cells
The wild-type and mutant STAT3–eGFP co-expression constructs
were transiently transfected into Neuro2A cells using Transfectin
(BioRad) at a ratio of 8 μl Transfectin to 4 μg cDNA per 100,000
cells. Neuro2A cells were incubated with the transfection mixture
for 12 h and allowed to recover for 24 h in complete medium before
experimentation. Successfully transfected cells were identiﬁed through
eGFP expression. For knockdown experiments, small interfering RNA
(siRNA) duplexes for murine RET (sc-36405) and NCAM (sc-36017)
were purchased from Santa Cruz. Brieﬂy, subconﬂuent cells (50–80%)
were transfected with siRNA duplexes (40 nM) using Transfectin
(Bio-Rad) for 24 h. Cells were serum deprived for 12–16 h before
stimulation with 50 ng/ml NRTN to induce signaling activation and
neurite outgrowth.2.5. Stable transfection of Neuro2A and retroviral infection of PC12 cells
The establishment of Neuro2A cells stably expressing GFRα2 isoforms
has been described previously [10]. Retroviral vector pQCXIN (Clontech,
Palo Alto, CA) carrying neomycin resistance gene was used to clone
the open reading frames (ORFs) of mouse GFRα2a (GenBank accession
number: AF079108), GFRα2b (GenBank accession number: AF079107)
and GFRα2c (GenBank accession number: AF002701). Retroviral vector
pQCXIH (Clontech) carrying hygromycin B resistance gene was used to
clone mouse ORF of RET9 (GenBank accession number: AY326397) and
RET51 (GenBank accession number: AF209436). Retroviral pQCXI-P vec-
tor carrying puromycin resistance gene was used to clone MTS-STAT3
constructs. Plat-E cells were transfected with these retroviral vectors
using FuGene 6 (Roche, Germany). Active retroviruses were collected
from supernatants and used to infect PC12 cells in the presence of
8 μg/ml of polybrene. PC12 cells were ﬁrst infected with combinations
of pQCXIN and pQCXIH vectors and selected over 2 month in com-
plete medium supplemented with 0.4 mg/ml G418 and 0.1 mg/ml
hygromycin B. The selected PC12 cells were then infected with retro-
viruses carrying different MTS-STAT3 mutants and further selected
over 2 months with 2 μg/ml Puromycin (Sigma). These engineered
PC12 cells were shown to stably overexpress wild type and mutant
MTS-STAT3 in the mitochondrial but not in the cytosolic fraction
[23].
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Total RNA fromprimary neurons or cultured PC12 andNeuro2A cells
was isolated using TRI-Reagent (Sigma) according tomanufacturer's in-
struction. The integrity of isolated total RNA was validated by denatur-
ing agarose gel electrophoresis and the concentration measured by
Nanodrop 2000 (Thermo Scientiﬁc). Two micrograms of total RNA
were reverse transcribed using ImPromII reverse transcriptase (Promega)
and 0.5 μg random hexamer for 60 min at 42 °C according to
manufacturer's instruction. The reaction was terminated by heating at
70 °C for 5 min.
2.7. Primers and qPCR
Real-time qPCR using SYBR Green I was performed on the CFX96
(Biorad, Hercules, CA) in a total volume of 25 μl in 1× XtensaMix-SG™
(BioWORKS, Singapore), containing 2.5 mM MgCl2, 200 nM of primers
and 0.5 U of KlearTaq DNA polymerase (KBiosciences, UK). Real-time
qPCR was carried out after an initial denaturation for 10 min at 95 °C
followed by 40 cycles of 30 s denaturation at 95 °C, 30 s annealing at
60 °C and 30 s extension at 72 °C. Melt curve analyses were performed
at the end of reaction to verify the identity of the products. The threshold
cycles (Ct) were calculated using the CFXmanager v1.6 (Biorad). All real-
time PCR quantiﬁcation was carried out simultaneously with linearized
plasmid standards and non-template controls. The expression levels of
GFRα2, RET isoforms and NCAMwere interpolated from standard curves
and normalized to the expressions of GAPDH in the same samples. The
primer sequences are as follows:Gene Forward primer Reverse primerGAPDH ACCACGAGAAATATGACAACTCCC CCAAAGTTGTCATGGATGACC
GFRα2a GCCTCTTCTTCTTTTTAGACGAA TGTCGTTCAGGTTGCAGGCCT
GFRα2b GCCTCTTCTTCTTTTTAGGTGAG TGTCGTTCAGGTTGCAGGCCT
GFRα2c GCCTCTTCTTCTTTTTAGGGACA TGTCGTTCAGGTTGCAGGCCT
RET9 CCCCTGGTGGACTGTAACA GTAAATGCATGTGAAATTCTACC
RET51 CCCCTGGTGGACTGTAACA TCGGCTCTCGTGAGTGGTA
NCAM TGTCAAGTGGCAGGAGATGC GGCGTTGTAGATGGTGAGGGT2.8. Western blot analysis
Primary cortical neurons, PC12 andNeuro2A cellswerewashed once
with PBS and subsequently lysed in lysis buffer containing 2% (w/v) SDS.
Protein concentrationswere quantiﬁed using themicroBCA assay (Pierce,
Rockford, IL). The protein samples were separated by SDS-PAGE gel and
incubated with antibodies against Phospho-STAT3-ser727 (#9134, Cell
Signalling Technology [CST], Beverly, MA), Phospho-STAT3-tyr705
(sc-8059, Santa Cruz), Pan-STAT3 (#9132, CST), Phospho-ERK1/2
(#9101, CST), Pan-ERK1/2 (#9102, CST), PARP (#9542, CST), VDAC
(#4866, CST) or SOD1 (sc-11407, Santa Cruz). The protein bands were
developedwith ImmobilonWestern ChemilumHRP Substrate (Millipore,
Billerica, MA) on ChemiDoc XRS system (Biorad). The band intensities
were quantiﬁed with Quantity One 1-D Analysis software v4 (Biorad).
2.9. Preparation of nuclear and cytosolic extracts
The nuclear and cytosolic extracts were prepared using NE-PER®
Nuclear and Cytoplasmic Extraction Reagents (Pierce), according to
manufacturer's instruction. Brieﬂy, PC12 andNeuro2A cells werewashed
twice with ice-cold PBS and harvested by gentle scraping. Cells were
pelleted by centrifugation at 500 ×g for 5 min, resuspended in ice cold
CER I and incubated on ice for 10 min. The cells were then lysed by addi-
tion of ice cold CER II and centrifuged for 5 min at 16,000 ×g to separate
the cytosolic fraction (supernatant) from the nucleus (pellet). The pellet
was resuspended in ice cold NER and incubated on ice for 40 min with
occasional vortexing (15 s after every 10 min of incubation). The nuclearextracts (supernatant) were separated from the debris by centrifugation
at 16,000 g for 10 min.
2.10. Preparation of mitochondrial and cytosolic extracts
Mitochondrial and cytosolic extracts were prepared from PC12 and
Neuro2A cells using differential centrifugation, as previously described
[23]. Brieﬂy, the cells werewashed twicewith ice-cold phosphate buffer
saline (PBS) and harvested by gentle scraping. Cells were pelleted by
centrifugation at 500 ×g for 5 min and resuspended in ice cold mito-
chondria extraction buffer (50 mM HEPES pH 7.4, 68 mM sucrose,
200 mM D-mannitol, 50 mM KCl, 2 mM MgCl2, 5 mM EDTA, 10 μg/ml
aprotinin, 2 μg/ml pepstatin A, 10 μg/ml leupeptin, 50 mM NaF, 0.5 mM
sodium vanadate, 20 mM glycerol phosphate) and incubated on ice for
15 min to allow swelling. The cells were dounce homogenized with 60
strokes. The unbroken cells and nuclei were removed by centrifugation
at 800 ×g for 10 min at 4 °C. The supernatants were further centrifuged
at 10,000 ×g for 30 minat 4 °C to obtain the crudemitochondrial fraction.
The resulting supernatants were collected as the cytosolic extracts and
the crude mitochondrial pellet was washed once with extraction buffer
and collected by centrifugation at 10,000 ×g for 30 min at 4 °C.
2.11. Differentiation and assessment of neurite outgrowth
Neuro2A cells were seeded on 12-well cell culture plates (NUNC,
Finland) in DMEM supplemented with 10% FBS overnight. Upon attach-
ment, the cells were serum deprived (DMEM supplemented with 1%
FBS) for 12–16 h. Control and transfected cells were then treated with
50 ng/ml NRTN for 24 h to induce neurite outgrowth. For transient
STAT3 mutant expression experiments, infected cells were identiﬁed
by eGFP expression and those eGFP positive cells bearing at least one
neurite with the length equivalent to two cell-body length were scored.
More than 60 eGFP positive cells from three biological replicates were
counted. Stably infected PC12 cells were seeded on poly-D-lysine coated
12-well cell culture plates overnight in DMEM supplemented with 10%
FBS and 5% HS. Upon attachment, the cells were serum starved (DMEM
supplemented with 0.5% FBS and 0.25%HS) for 12–16 h. The cells were
then treatedwith 50 ng/ml NRTN for 48 h to induce neurite outgrowth.
For inhibitor studies in both cells, serumdeprived cellswere pre-treated
with selected pharmacological inhibitors for 1 h before NRTN stimula-
tion. After 24 or 48 h, the cells bearing at least one neurite with the
length equivalent to two cell-body length were scored. More than 300
cells from three biological replicates were counted to obtain the mean
and standard deviation. For studies ofmitochondria targeted STAT3mu-
tants, NRTN induced neurite outgrowth in PC12 clones stably express-
ing different mutants were analyzed using HCA-Vision (CSIRO, AU).
Brieﬂy, control and NRTN treated PC12 cells were ﬁxedwith 4% parafor-
maldehyde (PFA; BDH Laboratory, UK). The cell bodies and neurites
were stained with Imperial Stain (Pierce) and the nuclei with 1 μg/ml
Hoescht 33342 (Sigma). All images of control and NRTN treated cells
were acquiredwith identical imaging parameters using a Zeiss Axio Ob-
server Z1 Inverted Microscope (Carl Zeiss, Germany). The images were
batch analyzed using HCA-Vision through a 3-step analysis including
Neuron Body Detection, Neurite Detection and Neurite Analysis, with
identical parameters. Signiﬁcant differences in neurite outgrowth be-
tweenwild type and STAT3mutant expressing PC12 cellswere calculat-
ed using the paired Student's t-test. A value of p b 0.05 was considered
signiﬁcant (**p b 0.01; *p b 0.05).
2.12. Immunocytochemistry
Control and NRTN treated Neuro2A, PC12 Cells and rat embryonic
cortical neurons were ﬁxed with 4% paraformaldehyde in PBS for
15 min at 37 °C, subsequently permeabilized in 0.5% Triton-X100/ PBS
and blocked with normal goat serum (1:10; Dako, Glostrup, Denmark)
in 0.5% Triton X-100/ PBS for 45 min at 37 °C. The cells were then
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#9134, 1:100 dilution) or GRIM-19 (Invitrogen #438900, 1:100 dilution)
in 0.3% Triton X-100/ 1% BSA/ PBS overnight at 4 °C and washed three
times in PBS. Subsequently, the cells were incubated with goat anti-
rabbit or goat anti-mouse ﬂuorescent secondary antibody (Alexa Fluor
488/ 596; Invitrogen, CA) diluted 1:400 in 0.3% Triton X-100/ 1%
BSA/ PBS for 2 h at 37 °C. The cells were washed three times in PBS
and mounted. For Mitotracker labeling, live Neuro2A or PC12 cells were
pre-incubated with 200 nM MitoTracker® Red CMXRos (Invitrogen
M7512) for 10 min before NRTN stimulation. Image acquisition was
performed using the Zeiss LSM710 with Axio Observer.Z1 confocal mi-
croscope equippedwith ﬂuorescence detection (Oberkochen, Germany).
Images of control and NRTN stimulated samples were taken with identi-
cal laser and optical settings. Colocalization coefﬁcients (Pearson correla-
tion coefﬁcient) between P-Ser-STAT3 and MitoTracker or P-Ser-STAT3
and GRIM-19 were analyzed with Zeiss ZEN software (v2010).
3. Results
3.1. NRTN induced STAT3 phosphorylation in cortical neuron expressing
multiple receptor isoforms
NRTN has been reported to exert neurotrophic effects on cortical
neurons [24], which express high levels of GFRα2 [10], making these
neurons a suitable model to investigate NRTN function and signaling.
In order to determine the expression levels of GFRα2 and its co-
receptors (RET and NCAM), total RNA was isolated from primary corti-
cal neurons (E18) and measured by RT-qPCR. All three isoforms of
GFRα2, GFRα2a, 2b and 2c were expressed at comparable levels in the
cultured primary cortical neurons (Fig. 1A). Co-receptor wise, RET9 iso-
form was found to be expressed at slightly higher level than RET51,
whereas NCAM expression was about ten-fold higher than that of
RET9. NRTN stimulation of cultured primary cortical neurons induced
rapid phosphorylation ofMAP kinase ERK. Intriguingly, NRTN treatment
resulted in serine but not tyrosine phosphorylation of STAT3 (Fig. 1B).
These data demonstrated that STAT3 can be activated by a GFL (NRTN)
and may be mediated by distinct combinations of receptor isoforms.
3.2. GFRα2c but not 2a or 2b mediated NRTN induced STAT3 serine
phosphorylation in Neuro2A cells
To test the hypothesis that NRTN induced P-Ser-STAT3 is mediated
through speciﬁc GFRα2 isoforms, Neuro2A cells were transfected to sta-
bly express either GFRα2a, 2b or 2c receptor isoforms (Figs. 1C, S1A).
Neuro2A cells endogenously express both RET andNCAMat levels com-
parable to that of primary cortical neurons but have negligible levels of
GFRα2, making these cells an ideal model to investigate GFRα2 isoform
function [10]. These GFRα2 isoform expressing Neuro2A cells were
stimulated with NRTN and the phosphorylation of STAT3 were mea-
sured. Consistent with the observation in primary cortical neurons,
NRTN did not induce tyrosine phosphorylation of STAT3 (Fig. 1D and F).
Surprisingly, NRTN stimulation of GFRα2c but not 2a or 2b was found to
signiﬁcantly induce sustained serine phosphorylation of STAT3 (Fig. 1D
and E), suggesting NRTN activation of STAT3 was mediated by speciﬁc
receptor isoform. Since STAT3 is known to mediate the neuritogenic
function of neurotrophic factors, we tested if STAT3 is involved in
NRTN induced neurite outgrowth. Wild type and mutant STAT3 were
transiently expressed in Neuro2A-GFRα2c cells using vector constructsFig. 1.NRTN induced sustained STAT3 serine727 but not tyrosine705 phosphorylation ismediated
rat embryonic cortical neurons were quantiﬁed by RT-qPCR with standard curves and norma
(100 ng/ml) for up to 3 h. Total cell lysates were collected and the protein expression analyzed
Neuro2A cells were quantiﬁed and normalized to GAPDH. D–F. Neuro2A-GFRα2a, 2b, 2c cells we
werenormalized to Pan-STAT3 and presented as fold change to control cells. G–H. Neuro2A-GFRα
NRTN to induce neurite outgrowth. The number of successfully transfected cells (eGFP expressing
G and the analyzed data inH. Signiﬁcant differences between thepercentages of neurite bearing c
t-test. A value of p b 0.05 was considered signiﬁcant (**p b 0.01; *p b 0.05).co-expressing enhanced green ﬂorescence protein (eGFP) as a marker
for gene transfer. STAT3 serine (S727A) but not tyrosine (Y705F) dom-
inant negative mutant was found to signiﬁcantly attenuate NRTN in-
duced neurite outgrowth (Fig. 1G and H). In addition, expression of
the STAT3 serine constitutive activemutant (S727E) resulted in a signif-
icant enhancement of neurite outgrowth, lending further evidence that
P-Ser-STAT3 was involved in NRTN induced neurite outgrowth. It is
noted that without NRTN stimulation, STAT3-S727E expression alone
did not result in neurite outgrowth (Fig. 1H). This suggested that serine727
phosphorylated STAT3 is required but not sufﬁcient to induce neurite
outgrowth in Neuro2A cells. Similarly, GDNF stimulation of Neuro2A-
GFRα2c cells resulted in STAT3 serine but not tyrosine phosphorylation
(Fig. S1D). Transient expression of STAT3 serine (S727A) dominant nega-
tivemutant impairedGDNF inducedneurite outgrowth (data not shown).
These data suggested that STAT3 can be activated by both ligands and in
turn mediated their neuritogenic functions. For the ease of presentation,
only data on NRTN was shown for experiments described below.
3.3. RET but not NCAM mediated NRTN induced STAT3 serine
phosphorylation in Neuro2A cells
Both RET and NCAMhave been shown to transduce GFL signal in the
presence of GFRα receptors. The involvement of these two receptors in
NRTN induced STAT3 phosphorylation was subsequently investigated.
Neuro2A cells were transiently transfected with siRNAs targeting RET
or NCAM. Transcript expressions of RET and NCAM were proﬁled and
both siRNAs were found to speciﬁcally suppress the respective target
mRNA level by more than 80% within 24 h (Fig. 2A). Transfection with
control siRNA did not signiﬁcantly affect the transcript levels of RET or
NCAM. The knockdown effect was further validated by immunoblotting
(Fig. S1B). Neuro2A cells stably expressingGFRα2cwere then transfected
with either RET or NCAM siRNAs and subsequently exposed to NRTN.
Upon ligand stimulation, sustained STAT3 serine phosphorylation was
observed in all but RET-siRNA transfected cells (Fig. 2B and C). Similarly,
NRTN induced ERKphosphorylationwas also abolished by RET siRNA but
not NCAM or control siRNA (Fig. 2D and E). Furthermore, NRTN induced
neurite outgrowth in Neuro2A cells stably expressing GFRα2cwas atten-
uated only by RET-siRNA treatment but not the others (Fig. 2F and G).
Collectively, these data demonstrated that RET but not NCAM is involved
in NRTN induced STAT3 phosphorylation and neurite outgrowth in
Neuro2A cells.
3.4. RET9 but not RET51 was responsible for NRTN induced STAT3 serine
phosphorylation in PC12 cells
RET9 andRET51 are two predominant isoforms generated by alterna-
tive splicing of RET pre-mRNA.We further tested if NRTN induced STAT3
phosphorylationwasmediated by a particular RET isoform, using anoth-
erwell-established neuronalmodel PC12 cells. The rat pheochromocyto-
ma PC12 cells expressed negligible amount of both GFRα2 and RET,
making it a suitable model to test the combinatorial interactions of
NRTN and its receptor isoforms. PC12 cells were transfected and stably
expressed combinations of GFRα2a, 2b or 2c with either RET9 or
RET51. The speciﬁc expressions of the desired receptor isoform combina-
tionwere conﬁrmed by RT-qPCR (Fig. 3A) and immunoblotting (Fig. S1A
and C). These cells were then stimulated with NRTN and the phosphory-
lation of STAT3 was measured. Consistent with the observation in
Neuro2A cells, NRTN stimulation of GFRα2a or 2b expressing PC12by speciﬁc GFRα2 isoforms. A. The transcript expressions of GFRα2, RET andNCAM in E18
lized to reference gene GAPDH. B. Cultured cortical neurons were stimulated with NRTN
by immunoblotting. C. Transcript expressions of various receptor isoforms in engineered
re stimulatedwith NRTN (50 ng/ml) for up to 3 h. NRTN induced P-Ser-STAT3, P-Tyr-STAT3
2c cellswere transiently transfectedwithwild-type andmutant STAT3 and stimulatedwith
) bearingneurite twice the cell body lengthwas scored. Representative images are shown in
ells in control and STAT3mutant expressing cellswere calculated using thepaired Student's
2793L. Zhou, H.-P. Too / Biochimica et Biophysica Acta 1833 (2013) 2789–2802cells did not induce signiﬁcant STAT3 phosphorylation regardless of the
co-expression of either RET9 or RET51 isoforms (Fig. S2A–C). Interesting-
ly, the combinatorial interaction of GFRα2c with RET9 but not RET51P-
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Fig. 2. RET but not NCAM mediated NRTN induced STAT3 serine phosphorylation in Neuro2A cells. A. Total RNA was extracted from Neuro2A-GFRα2c cells transiently transfected with
siRNA duplex speciﬁc for RET, NCAM or control siRNA. The transcript expressions of GFRα2c, RET and NCAM quantiﬁed by RT-qPCR with standard curves and normalized by GAPDH.
The effects of different siRNAs on these three genes are expressed as percentage knockdown from control cells. B–G. Neuro2A-GFRα2c transiently transfected with different siRNAs
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2794 L. Zhou, H.-P. Too / Biochimica et Biophysica Acta 1833 (2013) 2789–2802and PC12 cells further supported the hypothesis that NRTN and GDNF
activation of STAT3 was mediated by speciﬁc combinations of GFRα2
and RET receptor isoforms. Furthermore, IL6 but not NRTN or NGF
stimulation of PC12-GFRα2c-RET9 resulted in phosphorylation of Jak1(Fig. S1F), suggesting that NRTN activation of STAT3 was not mediated
by Jak-STAT3 pathway. Since Jak was shown to be essential for STAT3
tyrosine phosphorylation [25], the data provided a plausible explana-
tion for the inability of NRTN to induce STAT3 tyrosine phosphorylation.
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Multiple signaling pathways have been implicated in STAT3 serine
phosphorylation. We subsequently investigated the involvement of Src,
MAPKs (ERK, JNK and p38) and PKC in NRTN induced STAT3 serine phos-
phorylation. Neuro2A and PC12 co-expressing GFRα2c and RET9 cells
were pretreatedwith pharmacological inhibitors, and subsequently stim-
ulated with NRTN for varying periods of time. Interestingly, inhibition of
Src (SU6656) and ERK (U0126) but not JNK (SP600125), p38 (SB203580)
or PKC (Gö6983) was found to signiﬁcantly attenuate NRTN induced
STAT3 serine phosphorylation, in both Neuro2A (Figs. 4A and C, S2D)
and PC12 cells (Figs. 4B and D, S2E). It is worthy to note that JNK,
which we found to mediate NGF induced STAT3 serine phosphorylation
in PC12 cells, was similarly activated by NRTN but was not involved in
NRTN-STAT3 signaling transduction. The data suggested that distinct
combinations of signaling nodes are involved in STAT3 activation by dif-
ferent neurotrophic factor systems. Intriguingly, inhibition of Src and ERK
but not JNK, p38 or PKC pathway attenuated NRTN induced neurite out-
growth in Neuro2A (Fig. 4E) and PC12 cells (Fig. 4F). The correlation be-
tween the involvements of these pathways in NRTN induced neurite
outgrowth and STAT3 phosphorylation was suggestive of the role of
STAT3 as a downstream mediator of neurite outgrowth.
Unexpectly, RET9 but not RET51 was found to induce Src Y416 phos-
phorylation (Fig. 4G and H) in PC12 cells. In addition, inhibition of Src at-
tenuated RET9 mediated neurite outgrowth but not RET51 (Fig. 4I and J).These data showed that RET isoform speciﬁc phosphorylation of STAT3
was correlated to the differential activation of Src by RET9 but not RET51.3.6. NRTN induced P-Ser-STAT3 was undetectable in nucleus
STAT3 is known to mediate ligand-receptor signaling through tran-
scriptional activation of target genes. Ligand induced STAT3 nuclear
translocation and its kinetics affects the temporal expressions and func-
tions of the target genes. To test if NRTN induced STAT3 phosphoryla-
tion resulted in its nuclear translocation and target gene expression,
nuclear and cytosolic fractions were prepared from control and NRTN
stimulated PC12 cells. In addition, IL6, which has been shown to induce
rapid nuclear translocation of STAT3 in PC12 cells [26], was used as a
control. Both NRTN and IL6 induced rapid ERK phosphorylation and its
increased nuclear localization (Fig. 5A–C). Similarly, phosphorylated
STAT3was detected in nuclear fractionswithin 10 min of IL6 stimulation
andwas sustained over 6 h (Fig. 5A, D–F). In contrast, STAT3was not de-
tectable in the nucleus in cells stimulated with NRTN over the period of
6 h. Likewise, in Neuro2A cells, NRTN stimulation was found to induce
nuclear localization of ERK (Fig. S3A–C) but not STAT3 (Fig. S3A, D–F).
Collectively, the observations suggested that NRTN induced STAT3 serine
phosphorylation did not result in detectable nuclear localization, and that
P-Ser-STAT3 may mediate NRTN induced neurite outgrowth through a
transcriptional independent mechanism.
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Fig. 4. NRTN induced STAT3 serine phosphorylation was regulated by Src and ERK. Neuro2A and PC12 cells were pre-treated with DMSO (DM, 0.1%, control), SU6656 (SU, 1 μM), G 6983
(GO, 5 μM), U0126 (U, 10 μM), SP600125 (SP, 10 μM), and SB203580 (SB, 10 μM) for 1 h before stimulatedwith 50 ng/ml NRTN in the presence of respective inhibitors. A–B. The activations
of various signaling proteins were analyzed by immunoblotting. C–D. Quantiﬁed P-Ser-STAT3 immunoblot intensity was normalized by Pan-STAT3. The percentage inhibition of NRTN in-
duced STAT3 serine phosphorylation by various signalling inhibitorswas calculated as follows, % inhibition = (P-Ser-STAT3DMSO − P-Ser-STAT3Inhibitor) / P-Ser-STAT3DMSO × 100%. The ex-
periment was repeated and similar results were obtained. E–F. The effect of various inhibitors on NRTN induced neurite outgrowth in Neuro2A (E) and PC12 cells (F) were analyzed.
Signiﬁcantdifferences between the percentages of differentiated cells in control and inhibitor treated cellswere calculated using thepaired Student's t-test (**p b 0.01; *p b 0.05). G–H. Phos-
phorylation of Srcwas analyzed in NRTN stimulated PC12-GFRα2c-RET9 and PC12-GFRα2-RET51 cellswere analyzed and normalized to Pan-Src. I–J. Effect of Src inhibitors SU6656 onNRTN
induced neurite outgrowth in RET9 and RET51 cells were analyzed. Statistical signiﬁcance was calculated as mentioned above.
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upon NRTN stimulation
We have recently shown that NGF induced mitochondrial locali-
zation of P-Ser-STAT3 in PC12 cells [23]. In order to test the hypoth-
esis that NRTN induced P-Ser-STAT3may similarly be localized to themitochondria, cytosolic and mitochondrial fractions were isolated
from control and NRTN stimulated PC12 and Neuro2A cells. The presence
of P-Ser-STAT3, as well as total STAT3, in each fraction was analyzed by
immunoblotting. Interestingly, in both PC12 (Fig. 6A–C) and Neuro2A
cells (Fig. S4), NRTN stimulation increased the amount of P-Ser-STAT3de-
tected in mitochondrial fraction but not total STAT3. These observations
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were serine phosphorylated uponNRTN stimulation. Consistent with this
suggestion is that ERK, which has been shown to phosphorylate STAT3 at
serine727, was robustly activated in the mitochondria upon NRTN treat-
ment (Figs. 6, S4). These observations supported the hypothesis that
STAT3 may be phosphorylated in mitochondria by activated ERK or
other kinases.
To test if mitochondrial P-Ser-STAT3 signal was due to contamination
from the cytoplasm, immunoblot intensity ratios of P-Ser-STAT3 to the
cytosolic marker SOD1 in mitochondria and cytosol were compared as
previously described [23]. If the detected P-Ser-STAT3 in the mitochon-
dria was due to cytosolic contamination, the ratios of P-Ser-STAT3 to
SOD1 in both fractions should be similar. In PC12 cells, the intensity ratiosof P-Ser-STAT3 to SOD1 in the cytosol and mitochondria at 10 min were
1.5 and 7.6 respectively (Fig. 6). Similar observation was made in
Neuro2A cells (Fig. S4), indicating that mitochondrial P-Ser-STAT3 was
not due to cytosolic contamination. In addition, the total amount of
STAT3 in the mitochondria was estimated to be 11% of the cytosolic
STAT3 in PC12 cells and 15% in Neuro2A cells. The ratio of mitochondrial
ERK to cytosolic ERK was 22% in PC12 cells and 24% in Neuro2A cells.
These data are consistent with earlier reports from both our group [23]
and others [18,27], which provided further support to the reliability of
the isolation method and the experiments.
The presence of P-Ser-STAT3 in mitochondria was further vali-
dated by immunocytochemistry. NRTN stimulation signiﬁcantly in-
creased the ﬂorescent intensity of P-Ser-STAT3 and its co-localization
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Co-localization Coefﬁcient = 0.343) and Neuro2A cells (Fig. S4F, Co-
localization Coefﬁcient = 0.482). Moreover, NRTN induced P-Ser-
STAT3 was also found to co-localize with GRIM-19 (Figs. 7B, S4G,
Co-localization Coefﬁcient = 0.665 & 0.797 respectively), a known
STAT3 binding partner and a component of the mitochondrial electron
transport complex I [17,18,28,29]. Consistent with the observations in
cell lines, NRTN induced P-Ser-STAT3 was also found to co-localize
with MitoTrakcer (Fig. 7C, Co-localization Coefﬁcient = 0.543) as well
as GRIM-19 (Fig. 7D, Co-localization Coefﬁcient = 0.576) in primary cor-
tical neurons. Furthermore, the co-localization of P-Ser-STAT3 with
MitoTracker was observed not only in the cell body but also along the
neurites (Fig. 7E). Based on these observations, it is tempting to specu-
late that NRTNmay regulate local mitochondrial function along neurite
and in growth cone through mitochondrial localized P-Ser-STAT3. Col-
lectively, the data from subcellular fractionation and immunocyto-
chemical staining provided strong evidences that P-Ser-STAT3 was
localized to the mitochondria of neuronal cells upon NRTN stimulation.3.8.Mitochondrial STAT3 is an importantmediator of NRTN induced neurite
outgrowth
To investigate the role ofmitochondrial P-Ser-STAT3 inNRTN induced
neurite outgrowth, PC12 cells co-expressing GFRα2c and RET9 were sta-
bly transfectedwithmitochondrial targetedwild type andmutant STAT3
(MTS-STAT3). These MTS-STAT3 constructs have been used successfully
to investigate the functions of mitochondrial STAT3 [18,23,30] and
shown to speciﬁcally target the exogenously expressed STAT3 mu-
tants to the mitochondria [23]. The effect of different MTS-STAT3
mutants on NRTN induced neurite outgrowth was examined. Re-
markably, mitochondria targeted serine dominant negative mutant
of STAT3 (MTS-STAT3-SA) attenuated NRTN induced neurite out-
growth (Fig. 7F-G), while the wild type (MTS–STAT3-WT) and tyro-
sine dominant negative mutant (MTS-STAT3-YF) slightly enhanced
NRTN induced neurite outgrowth. These results demonstrated the
active role of mitochondrial P-Ser-STAT3 in mediating NRTN in-
duced neurite outgrowth.
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Fig. 7. Mitochondrial STAT3 was involved in NRTN induced neurite outgrowth. P-Ser-STAT3 was found to co-localize with MitoTracker (A,C) or GRIM-19 (B,D) in NRTN stimulated
(10 min) PC12 cells and primary cortical neurons. Shown here are the confocal images as well as the intensity correlations and co-localization coefﬁcients. E. P-Ser-STAT3 was found to
co-localize with MitoTracker not only in the cell body but along the neurites in primary cortical neurons. F–G. PC12 cells were engineered to stably express mitochondria targeting
STAT3 mutants. The average neurite length per cell in NRTN stimulated (50 ng/ml, 48 h) control and MTS-STAT3 cells was quantiﬁed using HCA-Vision. Fold changes in average neurite
length in NRTN treated cells over control were calculated. Signiﬁcant differences between control and mutant expressing PC12 cells were calculated using the paired Student's t-test. A
value of p b 0.05 was considered signiﬁcant (**p b 0.01; *p b 0.05). Representative images of control and NRTN treated cells are shown in G.
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This study demonstrated the novel functions of the alternatively
spliced receptor isoform GFRα2c and RET9 in mediating NRTN induced
STAT3 serine phosphorylation. Unlike previous studies on oncogenic
RET, this is the ﬁrst report of the activation of STAT3 by a GDNF family
ligand through GFRα and wild type RET. Furthermore, P-Ser-STAT3
was found to localize to the mitochondria instead of the nucleus and
mediated NRTN induced neurite outgrowth independent of its tran-
scriptional activities.
Recent study has found 92–94% of human genes to be alternatively
spliced [31]. In many systems, alternative splicing has produced multi-
ple isoformswith distinct biochemical properties, thus allowing a single
gene to exert a diverse range of biological functions [32]. Among dif-
ferent tissues, it was found that the greatest amount of conserved al-
ternative splicing occurs in the central nervous system [33]. Our
group has previously identiﬁed three distinct spliced isoforms of
GFRα2, the canonical receptor for NRTN [8]. The three isoforms were
further shown to mediate differential signalling activation and exerted
opposing neuritogenic functions. NRTN activation of GFRα2b inhibited
neurite outgrowth whereas GFRα2a and 2c induced neurite outgrowth
[10]. Using exon-overlapping qPCR assays that speciﬁcally detect each
of the isoforms [34], we have shown that all three isoforms are highly
expressed in the cortex [10], the region of the brain involved in learning
complex tasks. This is consistent with the observation that GFRα2
knockout mice show signiﬁcant impairment in memory tasks [35].
Moreover, NRTN has also been shown to provide both functional and
structural neuroprotection for cortical neurons in mouse model of
Huntington's Disease [24]. However, the signalling mechanisms under-
lying NRTN functions in cortical neurons and the roles of different
GFRα2 isoforms have yet to be thoroughly investigated.
In cultured embryonic cortical neurons, NRTN stimulation resulted
in rapid phosphorylation of ERK and STAT3 serine but not tyrosine res-
idue. A classic transcription regulator, STAT3 was ﬁrst discovered as a
key mediator of cytokine induced inﬂammation and immunity [36,37].
Later studies have found STAT3 to regulate a much wider range of bio-
logical processes including neuritogenesis and neuroprotection [13]. In
cortical neurons, NRTN signaling is thought to be mediated by GFRα2,
whichwere shown to be highly expressed in the cortex [10,38], through
co-receptors RET and/ or NCAM. While selected early studies have sug-
gested the lack of RET expression in the cortex of adult and neonatal rats
[38,39], more recent publications have reported the presence of RET in
both embryonic and adult cortical neurons [40,41]. This is consistent
with our ﬁndings, using real-time quantitative PCR, that both RET
isoformswere expressed in cultured embryonic day 18 cortical neurons.
To investigate the mechanism of NRTN activation of STAT3 and the role
of receptor isoforms, we engineered two well used neuronal models to
express different combinations of GFRα2 and RET receptor isoforms. In-
triguingly, the shortest isoform GFRα2c but not GFRα2a or 2b was able
to mediate sustained STAT3 serine phosphorylation upon NRTN stimu-
lation. GFRα receptor has been partially crystallized and is thought to be
structurally organized into three distinct domains [42–44]. GFRα2c,
with exon 2 and 3 deletion [8], differs from the other two isoforms in
its N terminus domain, which has been shown to be dispensable for li-
gand binding [45]. This is consistent with our earlier ﬁndings that GFL
bound equally well to all three GFRα2 isoforms in Neuro2A cells [10].
To explain the distinct functions of these isoforms, we postulated that
the N-terminal domainmay be an important determinant of the overall
conformation of the GFL-GFRα-RET/NCAM complex and the preferen-
tial activation of certain downstream signalling pathways. This is sup-
ported by recent ﬁndings that the N-terminal domain of GFRα1 is
important for the interactions with co-receptor RET [46] and NCAM
[47]. Co-crystallization of the entire GFL-GFRα-RET/NCAM complexes
containing different isoforms would provide the most direct means of
investigating the impact of the isoform speciﬁc N-terminal domain.
This is becoming increasingly feasible with the advancement in proteincrystallization technologies. As an alternative means, we are currently
investigating the phosphorylation patterns of co-receptor RET when
coupled to different GFRα2 isoforms, in an attempt to provide further
insights into their distinct biochemical properties. Nonetheless, our
ﬁnding that GFRα2c but not 2a or 2b was capable to inducing STAT3
phosphorylation provided further evidence to the distinct functions of
the GFRα2 receptor isoforms [9,10].
In addition, ligand bound GFRα has been shown to either partner
with RET or NCAM to transduce its signals. NCAM but not RET was
found to mediate GFRα1b isoform induced glioma migration [48]. In
contrast, this study found RET but not NCAM to mediate NRTN induced
STAT3 phosphorylation and neurite outgrowth, even though the ex-
pression level of NCAM in Neuro2A cells was signiﬁcantly greater than
RET. These data suggested that the selective partnering of GFRα with
its co-receptors vary in a cell context dependent manner and was not
determined solely by the expression levels of different co-receptors.
Furthermore, the alternatively spliced isoform RET9 but not RET51 was
found tomediate NRTN induced STAT3 phosphorylation. The two RET ty-
rosine kinase isoforms share 16 identical tyrosine residues but RET51 con-
tains two additional tyrosine residues in the carboxyl terminal (tyrosine
1090 and 1096). Mounting evidences have demonstrated the distinct
functions of RET9 and 51 in different cell types. RET9 but not
RET51 was able to promote tube formation of epithelial cells [49].
In contrast, RET51 but not RET9 was found to promote the survival
and tubulogenesis of mouse inner medullary collecting duct cells
[50], suggestive of isoform-speciﬁc roles in embryo development
and organogenesis. Other studies have reported RET9 and RET51 to
engage distinct adaptor proteins and activate different signalling
pathways [11,51,52]. In PC12 cells, NRTN activation of RET9 but not
RET51 was found to induce phosphorylation of Src, an important signal-
ling intermediate that mediated STAT3 phosphorylation, thus providing
a plausible explanation for RET9 speciﬁc activation of STAT3. Whether
GFRα2 and RET isoforms are speciﬁcally expressed in selected popula-
tions of cortical neurons and induce targeted STAT3 phosphorylation
during development are currently being investigated. Such data would
further elucidate the temporal and spatial role of NRTN receptor isoforms
and STAT3 in neural development.
To date, the functional signiﬁcance of STAT3 serine phosphorylation
remains controversial. It has been shown to either enhance or suppress
the transcriptional activity of tyrosine phosphorylated STAT3. More re-
cently, we and others have shown that serine mono-phosphorylated
STAT3 could function independent of its transcriptional activities. The
observation that NRTN induced P-Ser-STAT3 did not localize to the nu-
cleus added further evidence to this body of knowledge. Our ﬁndings
that NRTN induced P-Ser-STAT3 was localized to the mitochondria in
both Neuro2A and PC12 cells are in congruence with our earlier report
where NGF induced mitochondrial STAT3 phosphorylation [23]. These
new data suggested that the involvement of mitochondrial STAT3 in
neurite outgrowth is not restricted to NGF, butmay be a commonmech-
anism shared by multiple neurotrophic factors. It is intriguing that P-
Ser-STAT3 was localized to the mitochondria not only in the cell body
but along the neurites as well. As neurite outgrowth is a dynamic and
reversible process and is inﬂuenced by local mitochondrial dynamics
[53–55], it is tempting to speculate that mitochondrial P-Ser-STAT3
may be an important transducer of the anterograde and/or retrograde
signaling of neurotrophic factors along neurites.
To the best of our knowledge, this study marked the ﬁrst report of
the activation of STAT3 by a ligand (NRTN) activated GFRα and the
non-oncogenic RET receptor. It further demonstrated that STAT3 serine
phosphorylation wasmediated speciﬁcally by receptor isoform GFRα2c
and RET9. P-Ser-STAT3 was intimately involved in NRTN induced
neurite outgrowth, in a transcription independent manner, through its
spatial localization to the mitochondria. Taken together, this study
provided novel insights into an intriguing role of receptor isoforms
in mediating NRTN induced mitochondrial STAT3 and neurite
outgrowth.
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